Clinical Trial Update: Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

View source ↗

Summary

This clinical trial investigated DNA changes in high-risk prostate cancer to determine prognosis, but the study status is withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Dr. Tamim Niazi | Conditions: Prostate Cancer | Status: WITHDRAWN